Regulation of epidermal growth factor receptor activity by crotoxin, a snake venom phospholipase A₂ toxin : A novel growth inhibitory mechanismDONATO, N. J; MARTIN, C. A; PEREZ, M et al.Biochemical pharmacology. 1996, Vol 51, Num 11, pp 1535-1544, issn 0006-2952, 9 p.Article

A rat monoclonal antibody which interacts with mammalian ornithine decarboxylase at an epitope involved in phosphorylationDONATO, N. J; WARE, C. F; BYUS, C. V et al.Biochimica et biophysica acta. 1986, Vol 884, Num 2, pp 370-382, issn 0006-3002Article

Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cellsDONATO, N. J; DUEN-HWA YAN; MIEN-CHIE HUNG et al.Cell growth and differentiation. 1993, Vol 4, Num 5, pp 411-419, issn 1044-9523Article

Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells : evidence for a distinct mechanismDONATO, N. J; ROSENBLUM, M. G; STECK, P. A et al.Cell growth and differentiation. 1992, Vol 3, Num 5, pp 259-268, issn 1044-9523Article

Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cellsDONATO, N. J; ROTBEIN, J; ROSENBLUM, M. G et al.Journal of cellular biochemistry. 1991, Vol 46, Num 1, pp 69-77, issn 0730-2312Article

Positive and negative selection for tumor necrosis factor responsiveness reveals an inhibitory role for EGF receptor in TNF-induced antiproliferationNISHIKAWA, K; ROTBEIN, J; VIJJESWARAPU, D et al.Lymphokine and cytokine research. 1994, Vol 13, Num 1, pp 37-45, issn 1056-5477Article

Characterization of human recombinant tumor necrosis factor-α antiproliferative effects on human cells in cultureROSENBLUM, M. G; DONATO, N. J; GUTTERMAN, J. U et al.Lymphokine research. 1988, Vol 7, Num 2, pp 107-117, issn 0277-6766Article

Human, rat or mouse hybridomas secrete high levels of monoclonal antibodies following transplantation into mice with severe combined immunodeficiency disease (SCID)WARE, C. F; DONATO, N. J; DORSHKIND, K et al.Journal of immunological methods. 1985, Vol 85, Num 2, pp 353-361, issn 0022-1759Article

p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cellsPETERSON, L. F; MITRIKESKA, E; GIANNOLA, D et al.Leukemia. 2011, Vol 25, Num 5, pp 761-769, issn 0887-6924, 9 p.Article

Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor : potential interaction with epidermal growth factor receptorPEREZ, M; HASCHKE, B; DONATO, N. J et al.Oncogene (Basingstoke). 1999, Vol 18, Num 4, pp 967-978, issn 0950-9232Article

Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells: correlation with cytotoxicityDONATO, N. J; GALLICK, G. E; STECK, P. A et al.The Journal of biological chemistry (Print). 1989, Vol 264, Num 34, pp 20474-20481, issn 0021-9258Article

An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259PENE-DUMITRESCU, T; PETERSON, L. F; DONATO, N. J et al.Oncogene (Basingstoke). 2008, Vol 27, Num 56, pp 7055-7069, issn 0950-9232, 15 p.Article

Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852PEREZ-SOLER, R; DONATO, N. J; MURRAY, J. L et al.Journal of clinical oncology. 1994, Vol 12, Num 4, pp 730-739, issn 0732-183XArticle

Tumor necrosis factor α and γ-interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cellsMUJOO, K; DONATO, N. J; LAPUSHIN, R et al.Journal of immunotherapy. 1993, Vol 13, Num 3, pp 166-174, issn 1053-8550Article

Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin : evidence of a role for DNA repair and epidermal growth factor receptorNISHIKAWA, K; ROSENBLUM, M. G; NEWMAN, R. A et al.Cancer research (Baltimore). 1982, Vol 52, Num 17, pp 4758-4765, issn 0008-5472Article

ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cellsWU, J; MENG, F; DONATO, N. J et al.Leukemia. 2010, Vol 24, Num 4, pp 869-872, issn 0887-6924, 4 p.Article

Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemiaGAO, H; LEE, B.-N; TALPAZ, M et al.Leukemia. 2005, Vol 19, Num 11, pp 1905-1911, issn 0887-6924, 7 p.Article

EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivityDONATO, N. J; PEREZ, M; KANG, H et al.Clinical cancer research. 2000, Vol 6, Num 1, pp 193-202, issn 1078-0432Article

Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cellsROSENBLUM, M. G; CHEUNG, L; KIM, S. K et al.Cancer immunology and immunotherapy. 1996, Vol 42, Num 2, pp 115-121, issn 0340-7004Article

Tumor necrosis factor α: a multifaceted peptide hormoneROSENBLUM, M. G; DONATO, N. J; AGGARWAL, B. B et al.CRC critical reviews in immunology. 1989, Vol 9, Num 1, pp 21-44, issn 0197-3355Article